Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer
Abstract Patient-derived xenograft (PDX) models of breast cancer are an effective discovery platform and tool for preclinical pharmacologic testing and biomarker identification. We established orthotopic PDX models of triple negative breast cancer (TNBC) from the primary breast tumors of patients pr...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-022-00502-1 |